Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press coverage in Publications and Media, and critical scientific insights within Industry News.

A Gut Makeover for the New Year

NY Times weighs in on new year's resolutions – specifically in regards to a new study which suggests that changing your eating habits can benefit your gut microbiota: "If you're making resolutions for a healthier new year, consider a gut makeover. Refashioning the community of bacteria and other microbes living in your intestinal tract, collectively known as the gut microbiome, could be a good long-term investment in...

Read More

Protein that activates immune response harms body's ability to fight HIV

Science Daily discusses that temporarily blocking a type of protein can restore immune function and more for people with chronic infection of the virus that causes AIDS: "In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV. Findings from a study in animals appear to demonstrate...

Read More

Taconic Biosciences Accounces All US and EU Rat Colonies Free of Rat Polyomavirus 2

Hudson, NY, - December 14, 2016 - Taconic Biosciences, a leading provider of genetically engineered mouse models and associated services to researchers worldwide, today announced that all US and European commercial rat colonies are free of a newly discovered agent. IDEXX BioResearch announced it has identified rat polyomavirus 2, a novel virus, at the 2016 American Association for Laboratory Animal Science National Meeting in Charlotte, NC. According...

Read More

Cleveland Clinic Unveils Top 10 Medical Innovations Most Likely To Be Game Changers

Cleveland Clinic's Newsroom details their top ten choices of medical innovations from 2016: "A panel of top doctors and researchers presents the advancements with the power to transform healthcare in 2017 Smart cars that reduce accidents and injuries. Immunotherapy that helps kids beat cancer without chemo. Stents that harmlessly dissolve when their work is done. These are some of the innovations that will enhance healing and change...

Read More

Humanizing Animals for Immuno-Oncology

Genetic Engineering & Biotechnology features Taconic Biosciences because of their expertise with Immuno-Oncology and Humanized mouse models: "Success in Humanizing Mice Has Inspired Similar Efforts in Rats, Pigs, and Other Animals. One of the major roadblocks to curing cancer is modeling the complexities of the disease; thus, increasingly refined models of the disease are necessary. The result has been a sizable increase in the number of genetically...

Read More

Guest Commentary: What if mice could be more like humans?

Dr. Michael Seiler is the author of this DDNews article because of his knowledge surrounding humanized mouse models, immuno-oncology, and genetically engineered mouse models: "Throughout their decades of use in medical research, there exist numerous examples where mice have failed to adequately parallel human biology, leading to considerable wastes of money, time and effort. Nevertheless, questioning the adequacy of mice as human surrogates remains controversial, in large...

Read More

Special Report on Drug Metabolism: Identifying toxicity

DDNews gives prominence to Taconic Biosciences' Dr. Michael Seiler because of his knowledge of the role of animal models influencing drug metabolism studies: "For healthcare providers, it must seem at times that prescribing a drug to a patient is a little like playing the video game app Minesweeper. You know that any drug you prescribe has gone through rigorous preclinical and clinical testing that has been vetted...

Read More

Taconic Biosciences to Breed and Distribute Three Copy Number Variant Models for Neurodevelopmental Disorder Studies

Models Were Custom Generated by Taconic and Validated in Collaboration with Innovative Medicines Initiative (IMI) Hudson, NY - September 14, 2016 - Taconic Biosciences, a leading provider of genetically engineered mouse models and associated services to researchers worldwide, announced it will provide global access to three new copy number variant models designed for the study of schizophrenia, autism and other neurodevelopmental disorders. Taconic will breed and distribute...

Read More

CRISPR mouse model boom, rat model renaissance

Nature Biotechnology spotlights Taconic Biosciences' Dr. Adriano Flora because of his expertise with CRISPR-engineered models: "CRISPR-Cas9 genome editing has rekindled interest in the rat as a model of human disease. The US National Institutes of Health awarded The Jackson Laboratory $28.3 million in August to produce 1,000 lines of genetically modified mice. The task, which would have seemed intractable a few short years ago[...]" Read the complete...

Read More

Breeding a New Generation of Germ-Free Lab Mice

Bloomberg Business Week News details germ-free breeding done at Taconic Biosciences: "Germantown, N.Y., population 1,900, lies a few miles east of the Hudson River amid rolling countryside dotted with a typical mix of apple orchards and vineyards. Its mouse-breeding factory, however, is like no other. At the main campus of Taconic Biosciences, in tidy rows of white warehouses, the company breeds hundreds of thousands of rodents each...

Read More